Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study

Table 2

Rheological properties of oral pyritinol 100 mg/day for two weeks in cerebrovascular disorders.

Variables	Before	After	value
Hematocrit %	45.7 ± 0.23	45.6 ± 0.76
Total serum protein g/dl	8.64 ± 0.21	8.55 ± 1.39
Fibrinogen g/l	3.78 ± 0.87	3.65 ± 0.071
Relative blood viscosity cP	4.33 ± 0.65	3.11 ± 0.29
Actual blood viscosity cP	3.3685 ± 0.021	2.1485 ± 0.038
WBV-HSR cP	6.6009 ± 0.032	5.472 ± 0.08
WBV-LSR cP	116.377 ± 0.165	86.184 ± 0.032
RRI	2.17 ± 0.011	2.17 ± 0.036
Plasma viscosity cP	1.55 ± 0.06	0.99 ± 0.05
Kinematic viscosity	3.18 ± 0.17	3.17 ± 0.07

WBV-HSR: whole blood viscosity high shear rate, WBV-LSR: whole blood viscosity low shear rate, and RRI: RBC rigidity index.